iBio Inc (IBIO)
2.37
+0.01
(+0.42%)
USD |
NYAM |
Dec 24, 11:06
iBio Cash from Investing (Quarterly): 0.713M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 0.00 |
| Nanoviricides Inc | -0.0468M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.715M |
| Cash from Financing (Quarterly) | -0.162M |
| Free Cash Flow | -16.93M |
| Free Cash Flow Per Share (Quarterly) | -0.4303 |
| Free Cash Flow Yield | -125.2% |